1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow T cell immunodeficiency primary: new trials by email Literature Review of T cell immunodeficiency primary trials Research Report on T cell immunodeficiency primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2018-09-04 | 2026-03-17 |
Autoimmune Diseases (1) · Common Variable Immunodeficiency (1) · Immune System Diseases (1) · Lymphoproliferative Disorders (1) · Opportunistic Infections (1)
Hemic and Lymphatic Diseases (1) · Immunologic Deficiency Syndromes (1) · Immunoproliferative Disorders (1) · Infections (1) · Lymphatic Diseases (1)
Absorptiometry, Photon (1) · Antilymphocyte Serum (1) · Biopsy (1) · Busulfan (1) · Cyclophosphamide (1) · Electrocardiography (1) · Mesna (1) · Mycophenolic Acid (1) · Pentostatin (1) · Prednisone (1) · Respiratory Function Tests (1) · Tacrolimus (1)
National Cancer Institute (NCI) (1)
United States (1)